Tower Research Capital (TRC)’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Sell
2,435
-2,244
-48% -$167K ﹤0.01% 1803
2025
Q4
$371K Buy
4,679
+3,034
+184% +$232K 0.01% 1011
2025
Q3
$120K Buy
1,645
+148
+10% +$10.8K ﹤0.01% 1855
2025
Q2
$114K Sell
1,497
-3,617
-71% -$256K ﹤0.01% 2276
2025
Q1
$389K Sell
5,114
-1,617
-24% -$120K 0.01% 992
2024
Q4
$445K Buy
6,731
+2,804
+71% +$196K 0.01% 1150
2024
Q3
$274K Sell
3,927
-2,685
-41% -$161K 0.01% 1333
2024
Q2
$350K Buy
+6,612
New +$401K 0.01% 1632

Other funds holding SOLV

Tower Research Capital (TRC)'s SOLV Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Solventum (SOLV) stake by 48% in Q1 2026, selling an estimated $167K and leaving 2,435 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #1803.

Tower Research Capital (TRC) first reported a position in SOLV in Q2 2024 and has held it in 8 quarters since. The position peaked at $445K in Q4 2024. 877 funds tracked by Wall St. Rank hold SOLV as of Q1 2026.

  • Tower Research Capital (TRC) held 2,435 shares of Solventum worth $159K as of Q1 2026.
  • Tower Research Capital (TRC) sold 2,244 Solventum shares in Q1 2026, an estimated $167K.
  • Solventum made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1803 holding.
  • Tower Research Capital (TRC) first reported a position in Solventum in Q2 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Solventum position peaked at $445K in Q4 2024.
  • 877 funds tracked by Wall St. Rank held Solventum as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.